Authors:
de Witte, H
van den Hurk, M
Sweep, F
Benraad, T
Geurts-Moespot, A
Ruiter, D
Verhofstad, A
Citation: H. De Witte et al., Development of quality control preparations for immunocytochemical assessment of urokinase-type plasminogen activator, APPL IMMUNO, 9(3), 2001, pp. 281-287
Authors:
Span, P
Heuvel, J
Romain, S
Piffanelli, A
Martin, PM
Geurts-Moespot, A
Sweep, F
Citation: P. Span et al., EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols, ANTICANC R, 20(2A), 2000, pp. 681-687
Authors:
Abendstein, B
Daxenbichler, G
Windbichler, G
Zeimet, AG
Geurts, A
Sweep, F
Marth, C
Citation: B. Abendstein et al., Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients, ANTICANC R, 20(1B), 2000, pp. 569-572
Authors:
Floridon, C
Nielsen, O
Holund, B
Sweep, F
Sunde, L
Thomsen, SG
Teisner, B
Citation: C. Floridon et al., Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies, PLACENTA, 21(8), 2000, pp. 754-762
Authors:
Grebenschikov, N
Sweep, F
Geurts, A
Andreasen, P
De Witte, H
Schousboe, S
Heuvel, J
Benraad, T
Citation: N. Grebenschikov et al., ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA similar to PAI-1 and tPA similar to PAI-1), INT J CANC, 81(4), 1999, pp. 598-606